Company Growth (employees)
Zimmer Biomet was founded in 1927 and is headquartered in Warsaw, US
Zimmer Biomet Office Locations
Zimmer Biomet has an office in Warsaw
Warsaw, US (HQ)
345 E Main St
Zimmer Biomet Data and Metrics
Zimmer Biomet Financial Metrics
Zimmer Biomet's revenue was reported to be $7.7 b in FY, 2016 which is a 28% increase from the previous period.
USD
Revenue (FY, 2016) | 7.7 b |
Revenue growth (FY, 2015 - FY, 2016), % | 28% |
Gross profit (FY, 2016) | 5.3 b |
Gross profit margin (FY, 2016), % | 69% |
Net income (FY, 2016) | 304.6 m |
EBIT (FY, 2016) | 825.9 m |
Market capitalization (19-Sep-2017) | 23.4 b |
Closing share price (19-Sep-2017) | 116.3 |
Cash (31-Dec-2016) | 634.1 m |
EV | 34 b |
Zimmer Biomet's current market capitalization is $23.4 b.
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 4.6 b | 4.7 b | 6 b | 7.7 b |
Revenue growth, % | 1% | 28% | 28% | |
Cost of goods sold | 1.3 b | 1.2 b | 1.8 b | 2.4 b |
Gross profit | 3.3 b | 3.4 b | 4.2 b | 5.3 b |
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 1.1 b | 1.1 b | 1.5 b | 634.1 m |
Inventories | 1.1 b | 1.2 b | 2.3 b | 2 b |
Current Assets | 4.2 b | 4.3 b | 5.9 b | 4.7 b |
PP&E | 1.2 b | 1.3 b | 2.1 b | 2 b |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 759.2 m | 719 m | 146.2 m | 304.6 m |
Inventories | (128.4 m) | (154.1 m) | (205.4 m) | 76.4 m |
Cash From Operating Activities | 963.1 m | 1.1 b | 816.7 m | 1.6 b |
Cash From Investing Activities | (282.5 m) | (469.4 m) | (7.6 b) | (1.7 b) |
| USD | Y, 2016 |
|---|---|
EV/EBIT | 41.1 x |
EV/CFO | 20.8 x |
Revenue/Employee | 426.9 k |
Debt/Equity | 1.2 x |
Debt/Assets | 0.4 x |
Financial Leverage | 2.8 x |
Zimmer Biomet Market Value History
Market Position of Zimmer Biomet
Traffic Overview of Zimmer Biomet
Zimmer Biomet Online and Social Media Presence
Zimmer Biomet News and Updates
January 27, 2017
Trump’s Pick for Health Secretary Under Scrutiny for Investments
Democrats have called for investigations into whether Representative Tom Price violated insider trading laws or conflict of interest rules.
January 18, 2017
Senators call for investigation of Tom Price's healthcare investments
Democrats raise concern over health secretary nominee, who bought and sold health-related stocks while he was an influential voice on healthcare policyDonald Trump’s choice for health secretary, Tom Price, faces his first congressional grilling on Wednesday, hours after leading Democrats called for …
January 18, 2017
Senate panel to hear from Trump's Health secretary pick amid rising ethics questions
Amid rising criticism of his record and questions about his extensive trading in healthcare stocks, Rep. Tom Price is set to appear before the Senate Health Committee on Wednesday in his bid to become President-elect Donald Trump’s Health and Human Services secretary. Price, an orthopedic surgeo…
January 18, 2017
Editorial: Tom Price’s Dubious Trades in Health Care Stocks
The health secretary nominee needs to explain his investments as well as address confusion about the Trump team’s plans to replace Obamacare.
January 17, 2017
Trump Health Secretary Pick’s Longtime Foes: Big Government and Insurance Companies
Over a long political career, Tom Price, a doctor, never swerved from his policy mission to protect his former profession from what he views as heavy-handed government intrusion.
January 10, 2017
US Stock Indexes Edge Mostly Lower in Early Trading
Real estate companies led U.S. stocks mostly lower in early trading Tuesday. Energy and consumer-goods stocks also fell as crude oil prices headed lower. Industrials companies notched the biggest gain.